HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
11th World Congress on
CANCER RESEARCH AND THERAPY
Jul 07 - 08, 2025 at Vienna, Austria (Hotel NH Danube City)
HYBRID EVENT:You can Participate either IN-PERSON or virtually through ZOOM from your home/work.
After the grand success of previous cancer conferences, we solicit your gracious presence at the “11th World Congress on CANCER RESEARCH AND THERAPY" (WCCRT-2025) which will be conducted during July 07-08, 2025 as a hybrid event at Vienna, Austria and virtually. The conference will emphasize the theme “Novel Discoveries in Cancer Research & Treatment”.
Cancer Congress 2025 is now opening a call for sessions, aiming to develop a programme that brings together the very best of innovation and progress happening across the full spectrum of cancer control, at national, regional and global levels. This is a unique opportunity for cancer experts to share their knowledge and experience with the global cancer community, gain visibility and contribute to advancing cancer control.
Participants, presenters, keynote speakers, and volunteers will have access to world-class infrastructure, resources, and opportunities during the event, helping them achieve their professional goals. Additionally, the conference will provide opportunities for delegates to establish business and research relationships and engage in high-level business and scientific discussions. The conference will also serve as a valuable networking opportunity for future international collaborations in attendees' careers. These events will make significant contributions to your professional knowledge.
A special invitation is extended to international colleagues to attend and contribute to the conference.
The important benefits of attending this conference includes:
Targeted Audience:
Mark your calendars now and for more details, please contact us by email @ cancercongress@innovincinternational.com or Tel: +1-408-465-0048 WhatsApp number: +1-408-352-1010
Shanxi Cancer Hospital
China
Dalhousie University
Canada
Mansoura University
Egypt
Southern Illinois University Edwardsville
USA
Helmholtz Centre for Infection Research
Germany
University of Algarve
Portugal
INSERM/ University of Toulouse
France
Mansoura University, Egypt
University of Massachusetts Chan Medical School, USA
Baruch S Blumberg Institute, USA
Shanxi cancer hospital, China
Helmholtz Centre for Infection Research, Germany
Universidade Federal do Rio Grande do Norte, Brazil
University of Cyprus, Cyprus
Southern Illinois University Edwardsville, USA
Mayo Clinic, USA
Johns Hopkins University, USA
Chongqing University Cancer Hospital, China
Latvian Institute of Organic Synthesis, Latvia
Northwell Health Cancer Institute, USA
University of Bologna - Mayo Clinic, Italy
University of Haifa, Israel
The University of Akron, USA
Johns Hopkins University School of Medicine, USA
Genentech Inc, USA
Tel Aviv University, Israel
Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University, China
Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, China
Cliniques universitaires Saint Luc, Belgium
Mahidol University, Thailand
University Hospital of Muenster, Germany
Manisa Celal Bayar University, Turkey
Nanjing Medical University, China
INSERM/ University of Toulouse, France
University of South Carolina, USA
Shenzhen Hospital, Beijing University of Chinese Medicine, USA
Children's Hospital of Eastern Ontario, Canada
Latvian Institute of Organic Synthesis, Latvia
University of Haifa, Israel
Latvian Institute of Organic Synthesis, Latvia
University of Mostar School of Medicine, Bosnia and Herzegovina
Univeristy of Nevada, USA
Univeristy of Nevada, USA
The university of Hong Kong, Hong Kong
Shaowu Municiple Hospital, China
Mediterranean Institute of Oncology, Italy
Dalhousie University, Canada
Fujian Medical University, China
The First Affiliated Hospital of Nanchang University, China
University of Oxford, United Kingdom
Ankara University, Turkey
Dana-Farber Cancer Institute Harvard Medical School, USA
Genentech Inc., USA
Eastern R&D center, Israel
Sun Yat-sen University, China
Zhengzhou University, China
University Heidelberg, Germany
Henry Ford Health System, USA
Vanderbilt University Medical Center, USA
Jan Kochanowski University of Kielce, Poland
Jan Kochanowski University of Kielce, Poland
Harvard Medical School, USA
Affiliated Hospital of North Sichuan Medical College, China
Mackenzie Presbyterian University/OncoAI, Brazil
SBÜ Ankara Oncology Training and Researche Hospital, Turkey
Yale School of Medicine and Yale Cancer Center, USA
Institute of Molecular Physiology and Genetics, Centre of Biosciences, Slovak Academy of Sciences, Slovakia
Vall d´Hebron Research Institute, Spain
Slovak Academy of Sciences, Slovakia
Centre of Biosciences SAS, Slovakia
University of Mississippi Medical Center, USA
Don t Miss This Amazing Conference And Opportunities
Overall, the meeting was well organized and managed, the topics were interesting and in general well attended. The breaks and the services were timed and excellent.
I enjoyed speaking at the WCCRT Conference.
I really enjoyed the conference, very insightful presentation. I appreciate the opportunity to present and moderate the session.
Thank you very much for all your help. I enjoyed a lot last week in the 8th World Congress on CANCER RESEARCH AND THERAPY.
Thanks so much for the excellent WCCRT-2023! Many thanks also to all of your help! Yes, I would be very interested in next year's Cancer Congress 2024 in Prague, Czech Republic. Please keep me informed on the event
It was great congress!
I am looking forward to collaborating with you in the near future.
Great meeting, see you soon again
Thank you for giving me opportunity to present my research work. I enjoyed with all the talks.
It was a pleasure to took attendance in the conference. the speakers and studies were wide profile from different perspectives.
The conference was wonderful and it was a pleasure to present our talk
I really enjoyed the stay in Prague and hopefully I will be involved in next meeting in Vienna.
It was great and nice experience to attend the Cancer Congress in Prague.
Hope to be with you in Vienna meeting and keep in touch with me in the right time, our participants were very good really and we got close during lunch times.
This conference let me know about scholars' research online, which will be helpful for my future research. Of course, I hope to attend the meeting next year.
It was a great conference. Hopefully, I can also join in 2025.
It was a great pleasure to be part of the 10th WCCRT-24 in Prague, Czech Republic, which was very valuable and very informative. It was a great venue for medical researcher/professionals to get together and share the most current research findings on cancer research and therapy. Hopefully, I will be able to share more research results on the relationships between cancer and those environmental factors at the 11th WCCRT-25 in Vienna, Austria.